<DOC>
	<DOCNO>NCT00321113</DOCNO>
	<brief_summary>The purpose study explore safety efficacy two different immunosuppressive regimen ( sequential tacrolimus/mycophenolate mofetil [ MMF ] plus steroid versus tacrolimus plus MMF , follow induction daclizumab ) recipients marginal donor kidney .</brief_summary>
	<brief_title>Comparison Two Tacrolimus Based Immunosuppressive Regimens Recipients Receiving Marginal Donor Kidneys</brief_title>
	<detailed_description>An open , multicentre , randomize , parallel group study compare marginal old-for-old renal transplant patient safety efficacy two treatment : sequential mycophenolate mofetil/delayed tacrolimus plus steroids v tacrolimus plus mycophenolate mofetil , patient require induction anti-IL2 monoclonal antibody . Elderly ( ≥50 year ) low risk patient ( PRA grade ≤50 % , previous 6 month ) receive allograft transplantation marginal kidney ( ) elderly ( &gt; 65 year ) donor ( old-for-old allocation ) randomize one follow treatment arm : Arm1 : Sequential mycophenolate mofetil/tacrolimus/steroids Arm2 : Tacrolimus/mycophenolate mofetil/steroid one single dose ( perioperatively )</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Male female patient minimum 60 year age undergo cadaveric kidney transplant Patient end stage kidney disease suitable candidate primary renal transplantation . Donors older 60 year Female patient child bear age agree practice effective birth control study . Patient fully inform give write informed consent Patient significant , uncontrolled , concomitant infection and/or severe diarrhoea , vomit , active peptic ulcer Patient previously receive receive organ transplant kidney kidney retransplant Any pathology medical condition interfere protocol study proposal Other exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>MARGINAL KIDNEY</keyword>
	<keyword>TACROLIMUS</keyword>
	<keyword>IMMUNOSUPPRESSION</keyword>
	<keyword>ELDERLY RECEPIENTS</keyword>
</DOC>